Literature DB >> 2487611

Early rejection episodes.

J M Cecka, P I Terasaki.   

Abstract

1. Early rejection episodes had an overriding effect on graft survival. One-year graft survival decreased by 18% in LRD transplants and by 27% in cadaver-donor transplants when rejection occurred. Early rejection-free patients had 96% (LRD) and 87% (cadaver-donor) 1-year graft survival. 2. Among rejection-free recipients of first cadaver transplants, 1-year graft survival decreased by 5% when function was delayed for 8-14 days and by 10% when function was delayed more than 14 days, suggesting some rejections were masked by early nonfunction. 3. Rejections occurred in 30% of first cadaver donor transplants overall and ranged from 9-50% at individual contributing centers. Rejections occurred in 27% of LRD transplants and 37% of cadaver retransplants. 4. Histocompatibility affected the frequency of rejection as well as subsequent graft survival. The lowest incidence of rejection was 17% in HLA-identical sibling transplants, followed by 0 HLA-B,DR mismatched first cadaver transplants, with a progressive increase to 34% in completely mismatched (HLA-B,DR) first cadaver transplants. Parent and 1-haplotype sibling donor transplants were intermediate with a 30% incidence of rejection. In first cadaver transplant recipients with rejection, graft survival decreased from 78-59% with the degree of HLA mismatch. 5. Pretransplant transfusions also reduced the rejection frequency from 42% without to 24% with more than 4 transfusions.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2487611

Source DB:  PubMed          Journal:  Clin Transpl        ISSN: 0890-9016


  3 in total

1.  The possible role of early post-transplant inflammation in later anemia in kidney transplant recipients.

Authors:  Goran Imamović; Enver Zerem; Safet Omerović; Enes Osmanović; Emir Hodzić
Journal:  Bosn J Basic Med Sci       Date:  2009-11       Impact factor: 3.363

2.  Association of MCP-1 and CCR2 polymorphisms with the risk of late acute rejection after renal transplantation in Korean patients.

Authors:  S W Kang; S J Park; Y W Kim; Y H Kim; H S Sohn; Y C Yoon; H Joo; K H Jeong; S H Lee; T W Lee; C G Ihm
Journal:  Int J Immunogenet       Date:  2008-02       Impact factor: 1.466

3.  Development and Validation of the New Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Unbound Tacrolimus in the Plasma Ultrafiltrate of Transplant Recipients.

Authors:  Magdalena Bodnar-Broniarczyk; Karola Warzyszyńska; Katarzyna Czerwińska; Dorota Marszałek; Natalia Dziewa; Maciej Kosieradzki; Tomasz Pawiński
Journal:  Pharmaceutics       Date:  2022-03-12       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.